radiolabeled P5+14 (University of Tennessee Graduate School of Medicine)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameradiolabeled P5+14 (University of Tennessee Graduate School of Medicine)
Drug Alias Name125-Iodine-P5+14125I-p5+1499m-Technetium p5+1499mTC-p5+14
ClassificationBiologics > Protein drugs > Recombinant polypeptideRadiation-emitting products
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsAmyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesAttralus Inc
Active IndicationsAmyloidosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A